WO2025187876A1 - Compound which changes color by reacting with bodily substance - Google Patents
Compound which changes color by reacting with bodily substanceInfo
- Publication number
- WO2025187876A1 WO2025187876A1 PCT/KR2024/009983 KR2024009983W WO2025187876A1 WO 2025187876 A1 WO2025187876 A1 WO 2025187876A1 KR 2024009983 W KR2024009983 W KR 2024009983W WO 2025187876 A1 WO2025187876 A1 WO 2025187876A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- compound
- group
- general formula
- substituent
- carbon atoms
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/30—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/37—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
- C07C311/38—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring having sulfur atoms of sulfonamide groups and amino groups bound to carbon atoms of six-membered rings of the same carbon skeleton
- C07C311/39—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring having sulfur atoms of sulfonamide groups and amino groups bound to carbon atoms of six-membered rings of the same carbon skeleton having the nitrogen atom of at least one of the sulfonamide groups bound to hydrogen atoms or to an acyclic carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C211/00—Compounds containing amino groups bound to a carbon skeleton
- C07C211/43—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
- C07C211/57—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having amino groups bound to carbon atoms of six-membered aromatic rings being part of condensed ring systems of the carbon skeleton
- C07C211/58—Naphthylamines; N-substituted derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
- C07C217/56—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms
- C07C217/58—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms with amino groups and the six-membered aromatic ring, or the condensed ring system containing that ring, bound to the same carbon atom of the carbon chain
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/44—Iso-indoles; Hydrogenated iso-indoles
- C07D209/48—Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
- C09B57/00—Other synthetic dyes of known constitution
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/483—Physical analysis of biological material
- G01N33/487—Physical analysis of biological material of liquid biological material
- G01N33/493—Physical analysis of biological material of liquid biological material urine
Definitions
- the compound disclosed herein may be a colored compound, meaning that it may exhibit no or negligible color change over time. Furthermore, even more specifically, the compound disclosed herein may be a compound that undergoes a color change upon reaction with a component of the body.
- urine tests are performed as a method of in vitro diagnostics to detect information about the animals' internal organs.
- a compound containing a component that can react with various components contained in urine is applied to a substrate, and then urine is sprayed onto the substrate during diagnosis, thereby reacting the applied compound with the urine, thereby detecting biological information.
- the present specification discloses a compound.
- the present specification may disclose a colored compound or a composition containing the same, wherein the color change is negligible or absent.
- the present specification may disclose a compound or a composition containing the compound that exhibits a distinct red color change when reacting with a component in the body.
- each of the first substituent and the second substituent includes a unit derived from an alkyl group or an acyl group having 1 to 5 carbon atoms and including at the terminal any one of a benzene group, a benzene group substituted with ethoxy or methoxy, and a naphthalene group
- the third substituent includes a compound represented by the following general formula 1.
- R 1 and R 2 are each independently a phenyl group, a naphthalene group, a monovalent hydrocarbon group, or hydrogen, and n is a number in the range of 1 to 10.
- the present invention may disclose a compound in which the first substituent and the second substituent equally include a unit derived from an alkyl group or an acyl group having 1 to 5 carbon atoms, which includes at the terminal any one of a benzene group, a benzene group substituted with ethoxy or methoxy, and a naphthalene group.
- the present invention may disclose a compound in which, in the general formula 1, either one of R 1 and R 2 essentially contains a naphthalene group.
- the present invention may disclose a compound comprising a chemical formula derived from the following general formula 2.
- R 3 is an alkyl group having 1 to 10 carbon atoms, an alkylene group having 2 to 10 carbon atoms, or a benzene group
- R 4 and R 5 are each independently a monovalent hydrocarbon group, an alkyl group having 1 to 5 carbon atoms, or hydrogen.
- the present invention may disclose a compound further comprising the following chemical formula 1, wherein the chemical formula 1 is a compound formed under acidic conditions, wherein the chemical formula derived from the general formula 2 is a compound.
- R 6 and R 7 are each independently a monovalent hydrocarbon group, an alkyl group having 1 to 5 carbon atoms, or hydrogen.
- the present invention may disclose a compound wherein the acidic condition includes at least one of nitrous acid (HNO 2 ), fluoroboric acid (HBF 4 ), sulfuric acid (H 2 SO 4 ), and hydrochloric acid (HCl).
- HNO 2 nitrous acid
- HCF 4 fluoroboric acid
- H 2 SO 4 sulfuric acid
- HCl hydrochloric acid
- the present invention may also disclose a compound further comprising a compound corresponding to a diazonium salt.
- the present invention may also disclose a composition comprising the compound described above.
- the present specification discloses a compound.
- the present specification may disclose a colored compound or a composition comprising the same, wherein the color change is negligible or absent.
- the present specification may also disclose a compound or a composition comprising the same, which exhibits a distinct red color change upon reaction with a component of the body.
- Figures 1a and 1b are NMR of compound B.
- Figures 2a and 2b are NMR of compound C.
- Figures 3a and 3b are NMR of compound D.
- Figure 4 shows the results of observing the color and color change of an embodiment according to the present invention.
- properties whose results are affected by the measurement temperature are the results measured at room temperature, unless otherwise specifically stated.
- properties whose results are affected by the measurement temperature are the results measured at room temperature, unless otherwise specifically stated.
- room temperature means a natural temperature that has not been artificially heated or cooled, for example, a temperature within the range of 10°C to 30°C, or about 23°C or about 25°C.
- the unit of temperature is °C.
- atmospheric pressure refers to natural pressure that has not been artificially pressurized or depressurized, and is typically within the range of approximately 700 mmHg to 800 mmHg.
- Standard humidity means any humidity within the range of 40% to 60% relative humidity, for example, a relative humidity of approximately 40% or 60%.
- the present invention relates to a compound.
- a tertiary amine group means an amine having three substituents, or an ammonia (NH3) in which all three hydrogens are replaced by substituents other than hydrogen.
- each substituent of the tertiary amine group is described as a first substituent, a second substituent, and a third substituent.
- first to third substituents are for the convenience of description, and so their positions or orders are not particularly limited as long as they satisfy the first to third substituents disclosed in this specification.
- the compound comprising the tertiary amine group may include a unit derived from an alkyl group or an acyl group having 1 to 5 carbon atoms, each of which includes, as the first substituent and the second substituent, one of a benzene group, a benzene group substituted with ethoxy or methoxy, and a naphthalene group at the terminal.
- the first substituent or the second substituent is a unit derived from an alkyl group or acyl group having 1 to 5 carbon atoms and including a benzene group at the terminal, it may mean a structure in which the terminal of an alkyl group or acyl group having 1 to 5 carbon atoms and directly connected to nitrogen (N) is substituted with a benzene group.
- the first substituent or the second substituent is a unit derived from an alkyl group or acyl group having 1 to 5 carbon atoms and including a benzene group substituted with ethoxy or methoxy at the terminal
- it means a structure in which the terminal of the alkyl group or acyl group having 1 to 5 carbon atoms and directly connected to nitrogen (N) is substituted with a benzene group
- the benzene group substituted at the terminal of the alkyl group or acyl group having 1 to 5 carbon atoms and directly connected to nitrogen (N) can mean that the para-position is substituted with ethoxy or methoxy.
- the compound disclosed herein may be a compound in which the first substituent and the second substituent identically include a unit derived from an alkyl group or an acyl group having 1 to 5 carbon atoms, which includes at the terminal any one of a benzene group, a benzene group substituted with ethoxy or methoxy, and a naphthalene group.
- first substituent and the second substituent include the same unit derived from an alkyl group or acyl group having 1 to 5 carbon atoms is that the structural formula on the plane is the same regardless of the chemical stereostructure, for example, regardless of the RS system or the chiral structure.
- the first substituent and the second substituent include the same unit derived from an acyl group having at least one of a benzene group, a benzene group substituted with ethoxy or methoxy, and a naphthalene group at the end
- one of the benzene group, the benzene group substituted with ethoxy or methoxy, and the naphthalene group contained in the acyl group may be included as one at the end of the acyl group of the first substituent and the end of the acyl group of the second substituent, so that the first substituent and the second substituent may form a structure in which the benzene group, the benzene group substituted with ethoxy or methoxy, and the naphthalene group are connected.
- the tertiary amine may correspond to a
- the third substituent may be a compound represented by the following general formula 1.
- R1 and R2 can each independently be a phenyl group, a naphthalene group, a monovalent hydrocarbon group, or hydrogen.
- the compound may be a dye compound and thus advantageous in color change. More specifically, in the compounds disclosed herein, at least one of R1 and R2 may essentially include a naphthalene group. This naphthalene group has a structure in which two benzene groups are fused, and may be advantageous in immediately exhibiting a color change when reacted with a compound that reacts with the compounds disclosed herein.
- n is a number within the range of 1 to 10.
- n may be a number within the range of 1 to 6, and more preferably, 2 to 5.
- the compound disclosed in this specification may be a compound having a chemical formula derived from the following general formula 2.
- R3 can be an alkyl group, an alkylene group, or a benzene group.
- the lower limit of the carbon number of the alkyl group may be about 1, 2, 3, 4, 5 or 6, and the upper limit may be about 10, 9, 8, 7, 6 or 5.
- the carbon number of the alkyl group may be within a range exceeding or equal to the aforementioned lower limit or less than or equal to the aforementioned upper limit.
- the lower limit of the carbon number of the alkylene group may be about 2, 3, 4, 5, or 6, and the upper limit may be about 10, 9, 8, 7, 6, 5, or 4.
- the carbon number of the alkylene group may be in a range exceeding or equal to the aforementioned lower limit or less than or equal to the aforementioned upper limit.
- the alkylene group is in a form in which one hydrogen is removed from the carbons at both ends, and is different from an arylene group in which two hydrogens are removed from one carbon.
- R3 is an alkyl group, an alkylene group, or a benzene group
- N and SO2 are connected (or bonded) as an alkyl group, an alkylene group, or a benzene group.
- R4 and R5 can each independently be a monovalent hydrocarbon group, an alkyl group, or hydrogen.
- the lower limit of the carbon number of the alkyl group may be 1, and the upper limit may be about 5, 4, 3, or 2.
- the carbon number of the alkyl group may be in a range exceeding or equal to the aforementioned lower limit or less than or equal to the aforementioned upper limit.
- the compound disclosed in this specification may be a compound further comprising the following chemical formula 1, wherein the chemical formula 1 is a compound formed under acidic conditions with a chemical formula derived from the general formula 2.
- R6 and R7 are each independently a monovalent hydrocarbon group, an alkyl group having 1 to 5 carbon atoms, or hydrogen. Since chemical formula 4 corresponds to a chemical formula derived from the aforementioned general formula 2, the description of R6 and R7 is the same as R4 and R5 of the aforementioned general formula 2.
- the compound disclosed herein may be a compound in which the acidic condition under which the chemical formula 1 is formed includes at least one of nitrous acid (HNO2), fluoroboric acid (HBF4), sulfuric acid (H2SO4), and hydrochloric acid (HCl).
- HNO2 nitrous acid
- HHF4 fluoroboric acid
- H2SO4 sulfuric acid
- HCl hydrochloric acid
- the compound disclosed herein may be a compound further comprising a compound corresponding to a diazonium salt.
- the diazonium salt may be a salt formed by losing electrons under acidic conditions, having a chemical formula derived from the general formula 2 described above.
- the compounds disclosed herein or compositions containing the compounds may exhibit a certain level of color or more.
- color refers to the degree to which the compound or composition containing the compound itself exhibits color when observed with the naked eye.
- a color can be produced by reacting a compound containing the tertiary amine group described above with a compound containing a chemical formula derived from the general formula 2 described above.
- the colored compound or the composition containing it or the substrate on which the compound or the composition containing it is applied may have the advantage of showing little change in color over time as seen with the naked eye, thereby preventing quality deterioration or a decrease in the reliability of the results.
- the compounds disclosed herein or compositions containing them may exhibit a red color upon reaction with a component within the body.
- the color red encompasses all colors in the red family, including pink, scarlet, purple, and red.
- the component within the body may be, for example, sodium nitrite (NaNO2).
- the compound or composition containing the compound reacts with a component in the body, a red color appears, and the red color may become darker over time.
- the compounds or compositions containing the compounds disclosed herein may be used to detect biometric information.
- Methods for detecting biometric information using saliva, such as urine, are known.
- the method by which the compound disclosed herein or the composition containing the compound may react with sodium nitrite, such as adding sodium nitrite to the compound disclosed herein or the composition containing the compound, or adding the compound disclosed herein or the composition containing the compound to sodium nitrite, is not particularly limited.
- a method may be used in which the compound or the composition containing the compound is applied to a substrate and then reacted with sodium nitrite, and such a reaction method is also not particularly limited.
- the substrate may be exemplified by glass, a resin film, and natural cotton, but is not particularly limited as long as it is a method that can be considered by a person skilled in the art.
- Compound A having a chemical formula derived from general formula 2 was prepared.
- Compound A is the following compound in which R5 is a benzene group and R6 and R7 are hydrogen in general formula 2.
- Compound B containing a tertiary amine group was prepared by adding 103.6 mg of 1-naphthylethylenediamine dihydrochloride, 44.8 mg of KOH, and 108.9 ⁇ L of 4-Methoxybenzyl chloride to 4 mL of DMSO solvent at 0 °C and synthesizing for 5 hours.
- the molar mass of compound B is 426.56 g/mol.
- the NMR of compound B is as shown in Figures 1a and 1b.
- Fig. 1a and Fig. 1b are representations of a single drawing separated by line A, with Fig. 1a representing the left side and Fig. 1b representing the right side.
- FIG. 2a and FIG. 2b are representations of a single drawing separated by line B, with FIG. 2a representing the left side and FIG. 2b representing the right side.
- Figures 3a and 3b represent a single drawing divided by line C, with Figure 3a representing the left side and Figure 3b representing the right side.
- the mixture was mixed in the same manner as in Example 1, except that Compound C prepared in Manufacturing Example 3 was included instead of Compound B.
- the mixture was mixed in the same manner as in Example 1, except that Compound D prepared in Manufacturing Example 4 was included instead of Compound B.
- a composition containing 0.1 mg of NaNO 2 diluted with 1 mL of H 2 O was dropped into the mixture of Examples 1 to 3, which confirmed the colorability before the above reaction, and the color change was observed immediately thereafter. In addition, the color change was observed 10 minutes after the addition of NaNO 2 .
- NO + formed by NaNO 2 reacts with -NH 2 of compound A prepared in Manufacturing Example 1 to form a diazonium salt, and the diazonium salt thus formed reacts with any one of compounds B to D prepared in Manufacturing Examples 2 to 4 to form an Azo dye containing a naphthalene group and a benzene group with an N ⁇ N bond therebetween, thereby expressing a red color.
- Figure 4 shows the results of observing the color and color change of the example.
- Examples 1 to 3 are colored even before reacting with NaNO 2.
- NaNO 2 is added and the reaction proceeds, an Azo dye is quickly formed, causing a color change, and when the reaction has elapsed for about 10 minutes, an even darker color is exhibited.
- the compound disclosed in the present specification or a composition containing the same may be a compound or a composition containing the same that is colored before reacting with a biological component and does not or cannot detect a color change.
- the compound disclosed in the present specification or a composition containing the same can be a compound or a composition containing the same that can identify a biological component by exhibiting a color change after reaction with the biological component.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Physics & Mathematics (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Biophysics (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Materials For Medical Uses (AREA)
Abstract
Description
본 명세서는, 화합물을 개시한다. 보다 구체적으로, 본 명세서에서 개시하는 화합물은 유색을 띠는 화합물에 해당하는 것이어서 시간 경과 후 색변화가 없거나 무시할 정도인 화합물을 개시하는 것일 수 있다. 또한, 보다 더 구체적으로, 본 명세서에서 개시하는 화합물은 체내 성분과 반응하여 색변화가 이루어지는 화합물일 수 있다.This specification discloses a compound. More specifically, the compound disclosed herein may be a colored compound, meaning that it may exhibit no or negligible color change over time. Furthermore, even more specifically, the compound disclosed herein may be a compound that undergoes a color change upon reaction with a component of the body.
일반적으로, 동물들의 체내 정보를 검출하기 위하여, 체외진단의 한 방법으로 소변 검사가 이루어진다.Typically, urine tests are performed as a method of in vitro diagnostics to detect information about the animals' internal organs.
예를 들어, 소변에 포함된 여러 성분과 반응할 수 있는 성분을 포함하는 화합물을 기재에 도포해둔 상태에서, 진단 시 소변을 상기 기재에 분사하는 등의 방식으로 도포된 화합물과 소변을 반응하게 하여 생체 정보를 검출할 수 있다.For example, a compound containing a component that can react with various components contained in urine is applied to a substrate, and then urine is sprayed onto the substrate during diagnosis, thereby reacting the applied compound with the urine, thereby detecting biological information.
그런데, 이러한 종래 방식은 상기 기재에 도포된 상태의 화합물이나 이를 포함하는 조성물은 일정 시기가 지나면 화합물, 조성물 또는 이를 도포해둔 기재가 갈변되는 등의 문제가 있었다. 이러한 현상들은 기재(또는 검출 장비)의 품질이나 정확성을 의심하게 하고, 체내 정보를 검출하는 사람으로 하여금 검출 결과의 신뢰성을 떨어뜨린다는 문제가 있다.However, these conventional methods have been problematic, with compounds or compositions containing them applied to the substrate turning brown after a certain period of time. These phenomena raise doubts about the quality or accuracy of the substrate (or detection equipment) and can lower the reliability of detection results for those detecting body information.
이에 제공 시점과 사용 시점에서는 화합물 또는 기재의 색변화가 적고, 사용 시점에서는 뚜렷한 색변화를 나타내어 체내 정보를 확보할 수 있는 화합물을 제공하는 것이 필요하다.Accordingly, it is necessary to provide a compound that exhibits little color change in the compound or substrate at the time of provision and use, and exhibits a distinct color change at the time of use, thereby enabling the acquisition of information in the body.
본 명세서는, 화합물을 개시한다. The present specification discloses a compound.
또한 본 명세서는, 유색을 띠는 화합물 또는 이를 포함하는 조성물로서, 색변화가 없거나 무시할 정도인 화합물 또는 이를 포함하는 조성물을 개시하는 것일 수 있다.Additionally, the present specification may disclose a colored compound or a composition containing the same, wherein the color change is negligible or absent.
또한 본 명세서는, 체내 성분과 반응 시 붉은색의 색변화가 뚜렷한 화합물 또는 이를 포함하는 조성물을 개시하는 것일 수 있다.Additionally, the present specification may disclose a compound or a composition containing the compound that exhibits a distinct red color change when reacting with a component in the body.
상기 과제를 해결하기 위하여, 3차 아민기를 포함하는 화합물로서, 제 1 치환기 및 제 2 치환기 각각은, 벤젠기, 에톡시 또는 메톡시로 치환된 벤젠기 및 나프탈렌기 중 어느 하나를 말단에 포함하는 탄소수 1 내지 5인 알킬기 또는 아실기에서 유래된 단위를 포함하고, 제 3 치환기는, 하기 일반식 1로 표시되는 화합물을 포함하는, 화합물을 개시한다.In order to solve the above problem, a compound including a tertiary amine group is disclosed, wherein each of the first substituent and the second substituent includes a unit derived from an alkyl group or an acyl group having 1 to 5 carbon atoms and including at the terminal any one of a benzene group, a benzene group substituted with ethoxy or methoxy, and a naphthalene group, and the third substituent includes a compound represented by the following general formula 1.
[일반식 1][General Formula 1]
CnH2nNR1R2 C n H 2n NR 1 R 2
일반식 1에서, R1 및 R2는, 각각 독립적으로 페닐기, 나프탈렌기, 1가 탄화수소기 또는 수소이며, n은 1 내지 10의 범위 내의 수이다.In general formula 1, R 1 and R 2 are each independently a phenyl group, a naphthalene group, a monovalent hydrocarbon group, or hydrogen, and n is a number in the range of 1 to 10.
또한 본 발명은, 제 1 치환기 및 제 2 치환기는 벤젠기, 에톡시 또는 메톡시로 치환된 벤젠기 및 나프탈렌기 중 어느 하나를 말단에 포함하는 탄소수 1 내지 5인 알킬기 또는 아실기에서 유래된 단위를 동일하게 포함하는, 화합물을 개시하는 것일 수 있다.In addition, the present invention may disclose a compound in which the first substituent and the second substituent equally include a unit derived from an alkyl group or an acyl group having 1 to 5 carbon atoms, which includes at the terminal any one of a benzene group, a benzene group substituted with ethoxy or methoxy, and a naphthalene group.
또한 본 발명은, 상기 일반식 1에서, R1 및 R2 중 어느 하나는 나프탈렌기를 필수적으로 포함하는, 화합물을 개시하는 것일 수 있다.In addition, the present invention may disclose a compound in which, in the general formula 1, either one of R 1 and R 2 essentially contains a naphthalene group.
또한 본 발명은, 하기 일반식 2로부터 유래되는 화학식을 포함하는, 화합물을 개시하는 것일 수 있다.In addition, the present invention may disclose a compound comprising a chemical formula derived from the following general formula 2.
[일반식 2][General Formula 2]
H2NR3SO2NR4R5 H 2 NR 3 SO 2 NR 4 R 5
일반식 3에서, R3는, 탄소수 1 내지 10의 알킬기, 탄소수 2 내지 10의 알킬렌기 또는 벤젠기이고, R4 및 R5은, 각각 독립적으로 1가 탄화수소기, 탄소수 1 내지 5의 알킬기 또는 수소이다.In general formula 3, R 3 is an alkyl group having 1 to 10 carbon atoms, an alkylene group having 2 to 10 carbon atoms, or a benzene group, and R 4 and R 5 are each independently a monovalent hydrocarbon group, an alkyl group having 1 to 5 carbon atoms, or hydrogen.
또한 본 발명은, 하기 화학식 1을 더 포함하는 화합물로서, 상기 화학식 1은, 상기 일반식 2로부터 유래되는 화학식이 산성 조건에서 형성된 화합물인, 화합물을 개시하는 것일 수 있다.In addition, the present invention may disclose a compound further comprising the following chemical formula 1, wherein the chemical formula 1 is a compound formed under acidic conditions, wherein the chemical formula derived from the general formula 2 is a compound.
[화학식 1][Chemical Formula 1]
화학식 1에서, R6 및 R7는, 각각 독립적으로 1가 탄화수소기, 탄소수 1 내지 5의 알킬기 또는 수소이다.In chemical formula 1, R 6 and R 7 are each independently a monovalent hydrocarbon group, an alkyl group having 1 to 5 carbon atoms, or hydrogen.
또한 본 발명은, 상기 산성 조건은, 아질산(HNO2), 플루오로붕산(HBF4), 황산(H2SO4) 및 염산(HCl) 중 어느 하나 이상을 포함하는 것인, 화합물을 개시하는 것일 수 있다.In addition, the present invention may disclose a compound wherein the acidic condition includes at least one of nitrous acid (HNO 2 ), fluoroboric acid (HBF 4 ), sulfuric acid (H 2 SO 4 ), and hydrochloric acid (HCl).
또한 본 발명은, 다이아조늄염에 해당하는 화합물을 더 포함하는, 화합물을 개시하는 것일 수 있다.The present invention may also disclose a compound further comprising a compound corresponding to a diazonium salt.
또한 본 발명은, 전술한 화합물을 포함하는 조성물을 개시하는 것일 수 있다.The present invention may also disclose a composition comprising the compound described above.
본 명세서는, 화합물을 개시한다. 본 명세서는, 유색을 띠는 화합물 또는 이를 포함하는 조성물로서, 색변화가 없거나 무시할 정도인 화합물 또는 이를 포함하는 조성물을 개시할 수 있다. 또한 본 명세서는, 체내 성분과 반응 시 붉은색의 색변화가 뚜렷한 화합물 또는 이를 포함하는 조성물을 개시할 수 있다.The present specification discloses a compound. The present specification may disclose a colored compound or a composition comprising the same, wherein the color change is negligible or absent. The present specification may also disclose a compound or a composition comprising the same, which exhibits a distinct red color change upon reaction with a component of the body.
한편, 본 발명에서 얻을 수 있는 효과는 이상에서 언급한 효과들로 제한되지 않으며, 언급하지 않은 또 다른 효과들은 아래의 기재로부터 본 발명이 속하는 기술분야에서 통상의 지식을 가진 자에게 명확하게 이해될 수 있을 것이다.Meanwhile, the effects that can be obtained from the present invention are not limited to the effects mentioned above, and other effects that are not mentioned can be clearly understood by a person having ordinary skill in the technical field to which the present invention belongs from the description below.
도 1a와 도 1b는, 화합물 B의 NMR이다.Figures 1a and 1b are NMR of compound B.
도 2a와 도 2b는, 화합물 C의 NMR이다.Figures 2a and 2b are NMR of compound C.
도 3a와 도 3b는, 화합물 D의 NMR이다.Figures 3a and 3b are NMR of compound D.
도 4는 본 발명에 따른 실시예의 유색성 및 색변화를 관찰한 결과를 나타낸다.Figure 4 shows the results of observing the color and color change of an embodiment according to the present invention.
이하, 본 발명에 따른 화합물에 관하여 상세히 설명한다. 그러나, 화합물의 범위가 하기 설명에 의해 제한되는 것은 아니다.Hereinafter, the compounds according to the present invention will be described in detail. However, the scope of the compounds is not limited by the following description.
본 명세서에서 언급하는 물성 중에서 측정 온도가 결과에 영향을 미치는 물성은, 특별히 달리 언급하지 않는 한, 상온에서 측정한 결과이다.Among the properties mentioned in this specification, properties whose results are affected by the measurement temperature are the results measured at room temperature, unless otherwise specifically stated.
본 명세서에서 언급하는 물성 중에서 측정 온도가 결과에 영향을 미치는 물성은, 특별히 달리 언급하지 않는 한, 상온에서 측정한 결과이다.Among the properties mentioned in this specification, properties whose results are affected by the measurement temperature are the results measured at room temperature, unless otherwise specifically stated.
용어 상온은, 인위적으로 가온 및 감온되지 않은 자연 그대로의 온도이고, 예를 들면, 10 ℃내지 30 ℃의 범위 내의 어느 한 온도, 약 23 ℃또는 약 25 ℃정도의 온도를 의미한다. The term room temperature means a natural temperature that has not been artificially heated or cooled, for example, a temperature within the range of 10°C to 30°C, or about 23°C or about 25°C.
본 명세서에서 특별히 달리 규정하지 않는 한 온도의 단위는 ℃이다.Unless otherwise specified in this specification, the unit of temperature is ℃.
본 명세서에서 언급하는 물성 중에서 압력이 그 결과에 영향을 미치는 경우에는, 특별히 달리 규정하지 않는 한, 해당 물성은 상압에서 측정한 물성이다. 용어 상압은, 인의적으로 가압 및 감압되지 않은 자연 그대로의 압력으로서 통상 약 700 mmHg 내지 800 mmHg 범위 내의 정도의 압력을 상압으로 지칭한다.Among the properties mentioned in this specification, if pressure affects the results, unless otherwise specified, the properties are measured at atmospheric pressure. The term atmospheric pressure refers to natural pressure that has not been artificially pressurized or depressurized, and is typically within the range of approximately 700 mmHg to 800 mmHg.
본 명세서에서 언급하는 물성 중에서 습도가 그 결과에 영향을 미치는 경우에는, 특별히 달리 규정하지 않는 한, 해당 물성은 표준 상태의 습도에서 측정한 물성이다. 표준 상태의 습도는 상대 습도로 40% 내지 60%의 범위 내의 어느 한 습도, 예를 들면, 약 40% 또는 60%의 상대 습도를 의미한다.Among the properties mentioned in this specification, if humidity affects the results, unless otherwise specified, the properties are measured at standard humidity. Standard humidity means any humidity within the range of 40% to 60% relative humidity, for example, a relative humidity of approximately 40% or 60%.
본 발명은, 화합물에 관한 것이다.The present invention relates to a compound.
본 명세서는, 3차 아민기를 포함하는 화합물을 개시한다. 3차 아민기란, 3개의 치환기를 가지는 아민, 또는 암모니아(NH3)의 3개의 수소가 모두 수소 외의 다른 치환기로 치환되어 있는 것을 의미한다.The present specification discloses a compound comprising a tertiary amine group. A tertiary amine group means an amine having three substituents, or an ammonia (NH3) in which all three hydrogens are replaced by substituents other than hydrogen.
본 명세서에서는 기재의 편의를 위하여 3차 아민기의 각 치환기를 제 1 치환기, 제 2 치환기 및 제 3 치환기로 기재한다. 그렇지만 이러한 제 1 치환기 내지 제 3 치환기는 기재의 편의를 위한 것이어서, 본 명세서에서 개시하는 제 1 치환기 내지 제 3 치환기를 만족하는 경우라면 그 위치나 순서는 특별히 제한되는 것은 아니다.In this specification, for the convenience of description, each substituent of the tertiary amine group is described as a first substituent, a second substituent, and a third substituent. However, these first to third substituents are for the convenience of description, and so their positions or orders are not particularly limited as long as they satisfy the first to third substituents disclosed in this specification.
예를 들어, 상기 3차 아민기를 포함하는 화합물은 제 1 치환기 및 제 2 치환기 각각으로, 벤젠기, 에톡시 또는 메톡시로 치환된 벤젠기 및 나프탈렌기 중 어느 하나를 말단에 포함하는 탄소수 1 내지 5인 알킬기 또는 아실기에서 유래된 단위를 포함할 수 있다. For example, the compound comprising the tertiary amine group may include a unit derived from an alkyl group or an acyl group having 1 to 5 carbon atoms, each of which includes, as the first substituent and the second substituent, one of a benzene group, a benzene group substituted with ethoxy or methoxy, and a naphthalene group at the terminal.
예를 들어, 상기 제 1 치환기 또는 제 2 치환기가 벤젠기를 말단에 포함하는 탄소수 1 내지 5인 알킬기 또는 아실기에서 유래된 단위인 경우, 질소(N)와 직접 연결되는 탄소수 1 내지 5인 알킬기 또는 아실기의 말단에 벤젠기로 치환되어 있는 구조를 의미할 수 있다.For example, if the first substituent or the second substituent is a unit derived from an alkyl group or acyl group having 1 to 5 carbon atoms and including a benzene group at the terminal, it may mean a structure in which the terminal of an alkyl group or acyl group having 1 to 5 carbon atoms and directly connected to nitrogen (N) is substituted with a benzene group.
또한 예를 들어, 상기 제 1 치환기 또는 제 2 치환기가 에톡시 또는 메톡시로 치환된 벤젠기를 말단에 포함하는 탄소수 1 내지 5인 알킬기 또는 아실기에서 유래된 단위인 경우, 질소(N)와 직접 연결되는 탄소수 1 내지 5인 알킬기 또는 아실기의 말단에 벤젠기로 치환되어 있는 구조를 의미하며, 질소(N)와 직접 연결되는 탄소수 1 내지 5인 알킬기 또는 아실기의 말단에 치환되어 있는 벤젠기는 파라(para) 위치에 에톡시 또는 메톡시로 치환된 것을 의미할 수 있다.Also, for example, when the first substituent or the second substituent is a unit derived from an alkyl group or acyl group having 1 to 5 carbon atoms and including a benzene group substituted with ethoxy or methoxy at the terminal, it means a structure in which the terminal of the alkyl group or acyl group having 1 to 5 carbon atoms and directly connected to nitrogen (N) is substituted with a benzene group, and the benzene group substituted at the terminal of the alkyl group or acyl group having 1 to 5 carbon atoms and directly connected to nitrogen (N) can mean that the para-position is substituted with ethoxy or methoxy.
본 명세서에서 개시하는 화합물은, 상기 제 1 치환기 및 상기 제 2 치환기는 벤젠기, 에톡시 또는 메톡시로 치환된 벤젠기 및 나프탈렌기 중 어느 하나를 말단에 포함하는 탄소수 1 내지 5인 알킬기 또는 아실기에서 유래된 단위를 동일하게 포함하는, 화합물일 수 있다.The compound disclosed herein may be a compound in which the first substituent and the second substituent identically include a unit derived from an alkyl group or an acyl group having 1 to 5 carbon atoms, which includes at the terminal any one of a benzene group, a benzene group substituted with ethoxy or methoxy, and a naphthalene group.
상기 제 1 치환기 및 상기 제 2 치환기가 탄소수 1 내지 5인 알킬기 또는 아실기에서 유래된 단위를 동일하게 포함한다는 의미는, 화학적 입체 구조를 고려하지 않은 것으로서, 예를 들어 RS 체계를 고려하지 않거나, 카이랄 구조 등을 고려하지 않은 평면 상의 구조식이 동일한 것을 의미할 수 있다.The meaning that the first substituent and the second substituent include the same unit derived from an alkyl group or acyl group having 1 to 5 carbon atoms is that the structural formula on the plane is the same regardless of the chemical stereostructure, for example, regardless of the RS system or the chiral structure.
또한 예를 들어 상기 제 1 치환기 및 상기 제 2 치환기가 벤젠기, 에톡시 또는 메톡시로 치환된 벤젠기 및 나프탈렌기 중 어느 하나를 말단에 포함하는 아실기에서 유래된 단위를 동일하게 포함하는 경우, 상기 아실기에 포함된 벤젠기, 에톡시 또는 메톡시로 치환된 벤젠기 및 나프탈렌기 중 어느 하나는 상기 제 1 치환기의 아실기의 말단과 상기 제 2 치환기의 아실기의 말단에 하나로 포함되어 상기 제 1 치환기와 상기 제 2 치환기가 상기 벤젠기, 에톡시 또는 메톡시로 치환된 벤젠기 및 나프탈렌기로 이어져 있는 구조를 형성할 수도 있다. 예를 들어 상기 제 1 치환기와 상기 제 2 치환기가 벤젠기를 말단에 포함하는 아실기로 부터 유래된 단위인 경우, 상기 3차 아민은 프탈이미드계에 해당할 수 있다.In addition, for example, when the first substituent and the second substituent include the same unit derived from an acyl group having at least one of a benzene group, a benzene group substituted with ethoxy or methoxy, and a naphthalene group at the end, one of the benzene group, the benzene group substituted with ethoxy or methoxy, and the naphthalene group contained in the acyl group may be included as one at the end of the acyl group of the first substituent and the end of the acyl group of the second substituent, so that the first substituent and the second substituent may form a structure in which the benzene group, the benzene group substituted with ethoxy or methoxy, and the naphthalene group are connected. For example, when the first substituent and the second substituent are units derived from an acyl group having at least one benzene group at the end, the tertiary amine may correspond to a phthalimide group.
또한 제 3 치환기는, 하기 일반식 1로 표시되는 화합물일 수 있다.Additionally, the third substituent may be a compound represented by the following general formula 1.
[일반식 1][General Formula 1]
CnH2nNR1R2CnH2nNR1R2
일반식 1에서, R1 및 R2는, 각각 독립적으로 페닐기, 나프탈렌기, 1가 탄화수소기 또는 수소일 수 있다.In general formula 1, R1 and R2 can each independently be a phenyl group, a naphthalene group, a monovalent hydrocarbon group, or hydrogen.
예를 들어, R1 및 R2 중 어느 하나 이상이 페닐기 또는 나프탈렌기인 경우, 화합물은 dye 화합물에 해당하여 색변화에 유리할 수 있다. 보다 구체적으로 본 명세서에서 개시하는 화합물은 R1 및 R2 중 어느 하나는 나프탈렌기를 필수적으로 포함할 수 있다. 이러한 나프탈렌기는 2개의 벤젠기가 융합된 구조로서 본 명세서에서 개시하는 화합물과 반응하는 화합물과 반응할 때 곧바로 색변화를 나타내는 것에 유리할 수 있다.For example, if at least one of R1 and R2 is a phenyl group or a naphthalene group, the compound may be a dye compound and thus advantageous in color change. More specifically, in the compounds disclosed herein, at least one of R1 and R2 may essentially include a naphthalene group. This naphthalene group has a structure in which two benzene groups are fused, and may be advantageous in immediately exhibiting a color change when reacted with a compound that reacts with the compounds disclosed herein.
또한 일반식 1에서, n은 1 내지 10의 범위 내의 수이다. 바람직하게는 n은 1 내지 6, 보다 더 바람직하게는 2 내지 5의 범위 내의 수일 수 있다.Also, in general formula 1, n is a number within the range of 1 to 10. Preferably, n may be a number within the range of 1 to 6, and more preferably, 2 to 5.
본 명세서에서 개시하는 화합물은, 하기 일반식 2로부터 유래되는 화학식을 포함하는, 화합물일 수 있다.The compound disclosed in this specification may be a compound having a chemical formula derived from the following general formula 2.
[일반식 2][General Formula 2]
H2NR3SO2NR4R5H2NR3SO2NR4R5
일반식 2에서, R3는, 알킬기, 알킬렌기 또는 벤젠기일 수 있다.In general formula 2, R3 can be an alkyl group, an alkylene group, or a benzene group.
상기 R3이 알킬기인 경우, 알킬기의 탄소수의 하한은 1, 2, 3, 4, 5 또는 6 정도일 수 있고, 그 상한은 10, 9, 8, 7, 6 또는 5 정도일 수 있다. 상기 알킬기의 탄소수는 전술한 하한 초과 또는 이상이거나 전술한 상한 미만 또는 이하의 범위 내일 수 있다.When the above R3 is an alkyl group, the lower limit of the carbon number of the alkyl group may be about 1, 2, 3, 4, 5 or 6, and the upper limit may be about 10, 9, 8, 7, 6 or 5. The carbon number of the alkyl group may be within a range exceeding or equal to the aforementioned lower limit or less than or equal to the aforementioned upper limit.
또한 상기 R3이 알킬렌기인 경우, 상기 알킬렌기의 탄소수의 하한은 2, 3, 4, 5 또는 6 정도일 수 있고, 그 상한은 10, 9, 8, 7, 6, 5 또는 4 정도일 수 있다. 상기 알킬렌기의 탄소수는 전술한 하한 초과 또는 이상이거나 전술한 상한 미만 또는 이하의 범위 내일 수 있다. 알킬렌기는 양단의 탄소에서 수소가 하나씩 빠진 형태로, 하나의 탄소에서 두개의 수소가 빠진 아릴렌기와는 상이한 것이다. In addition, when the above R3 is an alkylene group, the lower limit of the carbon number of the alkylene group may be about 2, 3, 4, 5, or 6, and the upper limit may be about 10, 9, 8, 7, 6, 5, or 4. The carbon number of the alkylene group may be in a range exceeding or equal to the aforementioned lower limit or less than or equal to the aforementioned upper limit. The alkylene group is in a form in which one hydrogen is removed from the carbons at both ends, and is different from an arylene group in which two hydrogens are removed from one carbon.
상기 일반식 2에서 R3이 알킬기, 알킬렌기 또는 벤젠기라는 의미는, 일반식 2로부터 유래되는 화학식에서 N과 SO2가 알킬기, 알킬렌기 또는 벤젠기로 이어져(또는 결합되어) 있는 것을 의미할 수 있다.In the general formula 2 above, the meaning that R3 is an alkyl group, an alkylene group, or a benzene group may mean that in the chemical formula derived from the general formula 2, N and SO2 are connected (or bonded) as an alkyl group, an alkylene group, or a benzene group.
또한 일반식 2에서, R4 및 R5는, 각각 독립적으로 1가 탄화수소기, 알킬기 또는 수소일 수 있다.Also, in general formula 2, R4 and R5 can each independently be a monovalent hydrocarbon group, an alkyl group, or hydrogen.
상기 R4 및 R5 중 어느 하나 이상이 알킬기인 경우, 상기 알킬기의 탄소수의 하한은 1일 수 있고, 그 상한은 5, 4, 3 또는 2 정도일 수 있다. 상기 알킬기의 탄소수는 전술한 하한 초과 또는 이상이거나 전술한 상한 미만 또는 이하의 범위 내일 수 있다.When at least one of the above R4 and R5 is an alkyl group, the lower limit of the carbon number of the alkyl group may be 1, and the upper limit may be about 5, 4, 3, or 2. The carbon number of the alkyl group may be in a range exceeding or equal to the aforementioned lower limit or less than or equal to the aforementioned upper limit.
본 명세서에서 개시하는 화합물은, 하기 화학식 1을 더 포함하는 화합물로서, 상기 화학식 1은, 상기 일반식 2로부터 유래되는 화학식이 산성 조건에서 형성된 화합물인, 화합물일 수 있다.The compound disclosed in this specification may be a compound further comprising the following chemical formula 1, wherein the chemical formula 1 is a compound formed under acidic conditions with a chemical formula derived from the general formula 2.
[화학식 1][Chemical Formula 1]
화학식 1에서, R6 및 R7는, 각각 독립적으로 1가 탄화수소기, 탄소수 1 내지 5의 알킬기 또는 수소이다. 상기 화학식 4는, 전술한 일반식 2로부터 유래되는 화학식에 해당하기 때문에, R6 및 R7에 대한 설명은 전술한 일반식 2의 R4 및 R5 와 같다.In chemical formula 1, R6 and R7 are each independently a monovalent hydrocarbon group, an alkyl group having 1 to 5 carbon atoms, or hydrogen. Since chemical formula 4 corresponds to a chemical formula derived from the aforementioned general formula 2, the description of R6 and R7 is the same as R4 and R5 of the aforementioned general formula 2.
본 명세서에서 개시하는 화합물은, 상기 화학식 1이 형성된 산성 조건이, 아질산(HNO2), 플루오로붕산(HBF4), 황산(H2SO4) 및 염산(HCl) 중 어느 하나 이상을 포함하는 것인, 화합물일 수 있다.The compound disclosed herein may be a compound in which the acidic condition under which the chemical formula 1 is formed includes at least one of nitrous acid (HNO2), fluoroboric acid (HBF4), sulfuric acid (H2SO4), and hydrochloric acid (HCl).
본 명세서에서 개시하는 화합물은, 다이아조늄염에 해당하는 화합물을 더 포함하는, 화합물일 수 있다.The compound disclosed herein may be a compound further comprising a compound corresponding to a diazonium salt.
또한, 상기 다이아조늄염은 전술한 일반식 2로부터 유래되는 화학식이 상기 산성 조건에서 전자를 잃어 형성되는 염일 수 있다. In addition, the diazonium salt may be a salt formed by losing electrons under acidic conditions, having a chemical formula derived from the general formula 2 described above.
본 명세서에서 개시하는 화합물 또는 상기 화합물을 포함하는 조성물은 일정 수준 이상의 유색을 띨 수 있다. 본 명세서에서 유색은, 육안으로 관측할 때 화합물 또는 이를 포함하는 조성물 자체가 색을 띠는 정도인 경우를 의미한다.The compounds disclosed herein or compositions containing the compounds may exhibit a certain level of color or more. As used herein, color refers to the degree to which the compound or composition containing the compound itself exhibits color when observed with the naked eye.
전술한 3차 아민기를 포함하는 화합물과 전술한 일반식 2로부터 유래되는 화학식을 포함하는 화합물이 반응함으로써 유색을 띨 수 있다. A color can be produced by reacting a compound containing the tertiary amine group described above with a compound containing a chemical formula derived from the general formula 2 described above.
예를 들어 유색을 띠는 화합물 또는 이를 포함하는 조성물은, 기존에 색을 띠지 않는 무색의 화합물 또는 이를 포함하는 조성물 대비 보관 과정에서 색변화를 육안으로 감지하는 것이 어렵다.For example, it is difficult to visually detect a color change in a colored compound or a composition containing the same during the storage process compared to a colorless compound or a composition containing the same.
따라서, 상기 유색을 띠는 화합물 또는 이를 포함하는 조성물 자체나 이러한 화합물 또는 이를 포함하는 조성물이 도포된 기재는 육안상 시간 변화에 따른 색변화가 적어 품질 변질이나 이에 따른 결과의 신뢰성을 저하하지 않을 수 있다는 이점이 있을 수 있다.Accordingly, the colored compound or the composition containing it or the substrate on which the compound or the composition containing it is applied may have the advantage of showing little change in color over time as seen with the naked eye, thereby preventing quality deterioration or a decrease in the reliability of the results.
또한, 본 명세서에서 개시하는 화합물 또는 이를 포함하는 조성물은 체내 성분과 반응함으로써 붉은색을 띨 수 있다. 본 명세서에서 붉은색은 분홍색, 선홍색, 자주색 및 빨간색 등 붉은색 계열의 색을 띠는 것을 모두 포함한다. 또한, 상기 체내 성분은 예를 들어, 아질산나트륨(NaNO2)일 수 있다.Additionally, the compounds disclosed herein or compositions containing them may exhibit a red color upon reaction with a component within the body. As used herein, the color red encompasses all colors in the red family, including pink, scarlet, purple, and red. Furthermore, the component within the body may be, for example, sodium nitrite (NaNO2).
상기 화합물 또는 이를 포함하는 조성물이 체내 성분과 반응 시 붉은색이 나타나고, 시간 경과 후 붉은색은 더욱 짙은 색을 띨 수 있다.When the compound or composition containing the compound reacts with a component in the body, a red color appears, and the red color may become darker over time.
본 명세서에서 개시하는 화합물 또는 화합물을 포함하는 조성물은 생체 정보를 검출하는 용도일 수 있다. 이러한 생체 정보를 위해 소변 등과 같은 타액으로 생체 정보를 검출하는 방법은 공지이다. The compounds or compositions containing the compounds disclosed herein may be used to detect biometric information. Methods for detecting biometric information using saliva, such as urine, are known.
본 명세서에서 개시하는 화합물 또는 상기 화합물을 포함하는 조성물에 아질산나트륨을 첨가하거나, 아질산나트륨에 본 명세서에서 개시하는 화합물 또는 상기 화합물을 포함하는 조성물을 첨가하는 등 본 명세서에서 개시하는 화합물 또는 상기 화합물을 포함하는 조성물과 아질산나트륨이 반응할 수 있는 방법은 특별히 제한되는 것은 아니다. 또한, 첨가 외에 기재상에 화합물 또는 상기 화합물을 포함하는 조성물을 도포하는 등의 방식으로 포함한 후 아질산나트륨을 반응시킬 수 있는 방법일 수 있고, 이러한 반응 방법 또한 특별히 제한되는 것은 아니다. 또한, 상기 기재는 유리(glass), 수지필름 및 천연 면 등이 예시될 수 있으나 본 기술분야의 통상의 기술자가 고려할 수 있는 방식이라면 특별히 제한되는 것은 아니다.The method by which the compound disclosed herein or the composition containing the compound may react with sodium nitrite, such as adding sodium nitrite to the compound disclosed herein or the composition containing the compound, or adding the compound disclosed herein or the composition containing the compound to sodium nitrite, is not particularly limited. In addition, in addition to addition, a method may be used in which the compound or the composition containing the compound is applied to a substrate and then reacted with sodium nitrite, and such a reaction method is also not particularly limited. In addition, the substrate may be exemplified by glass, a resin film, and natural cotton, but is not particularly limited as long as it is a method that can be considered by a person skilled in the art.
이하, 본 발명을 구체적인 실험예를 통하여 보다 상세하게 설명한다. 그러나 이들 실험예는 본 발명을 예시적으로 설명하기 위한 것으로 본 발명의 범위가 이들 실험예에 한정되는 것은 아니다.Hereinafter, the present invention will be described in more detail through specific experimental examples. However, these experimental examples are intended to exemplify the present invention and the scope of the present invention is not limited to these experimental examples.
제조예 1 - 화합물 AManufacturing Example 1 - Compound A
일반식 2로부터 유래되는 화학식을 포함하는 화합물 A를 제조하였다. 화합물 A는 일반식 2에서 R5는 벤젠기, R6 및 R7는 수소인 하기 화합물이다. Compound A having a chemical formula derived from general formula 2 was prepared. Compound A is the following compound in which R5 is a benzene group and R6 and R7 are hydrogen in general formula 2.
[화합물 A][Compound A]
제조예 2 - 화합물 BManufacturing Example 2 - Compound B
0 ℃에서 DMSO 용매 4mL에 1-naphthylethylenediamine dihydrochloride 103.6mg, KOH 44.8mg 및 4-Methoxybenzyl chloride 108.9μL을 첨가하고 5시간 동안 합성하여 3차 아민기를 포함하는 화합물 B를 제조하였다. 화합물 B의 몰질량은 426.56 g/mol이다. 화합물 B의 NMR은 도 1a-도 1b와 같다.Compound B containing a tertiary amine group was prepared by adding 103.6 mg of 1-naphthylethylenediamine dihydrochloride, 44.8 mg of KOH, and 108.9 μL of 4-Methoxybenzyl chloride to 4 mL of DMSO solvent at 0 °C and synthesizing for 5 hours. The molar mass of compound B is 426.56 g/mol. The NMR of compound B is as shown in Figures 1a and 1b.
여기서, 도 1a와 도 1b는, 단일의 도면을 A선으로 분리하여 표현한 것으로, 도 1a는 좌측을 표현하고, 도 1b는 우측을 표현한다.Here, Fig. 1a and Fig. 1b are representations of a single drawing separated by line A, with Fig. 1a representing the left side and Fig. 1b representing the right side.
[화합물 B][Compound B]
제조예 3 - 화합물 CManufacturing Example 3 - Compound C
0 ℃에서 THF 용매 4mL에 1-naphthylethylenediamine dihydrochloride 103.6mg, Benzyl bromide 57.0μL을 첨가 후 10시간 교반한 후 K2CO3 165.8mg를 첨가한 뒤에 상온(약 25 ℃에서 12시간 동안 합성하여 3차 아민기를 포함하는 화합물 C를 제조하였다. 화합물 C의 몰질량은 366.51 g/mol이다. 화합물 C의 NMR은 도 2a-도 2b와 같다.At 0°C, 103.6 mg of 1-naphthylethylenediamine dihydrochloride and 57.0 μL of benzyl bromide were added to 4 mL of THF solvent, stirred for 10 hours, and then 165.8 mg of K2CO3 was added. Compound C containing a tertiary amine group was synthesized at room temperature (approximately 25°C) for 12 hours. The molar mass of compound C is 366.51 g/mol. The NMR of compound C is as shown in Figures 2a and 2b.
여기서, 도 2a와 도 2b는, 단일의 도면을 B선으로 분리하여 표현한 것으로, 도 2a는 좌측을 표현하고, 도 2b는 우측을 표현한다.Here, FIG. 2a and FIG. 2b are representations of a single drawing separated by line B, with FIG. 2a representing the left side and FIG. 2b representing the right side.
[화합물 C][Compound C]
제조예 4 - 화합물 DManufacturing Example 4 - Compound D
상온(약 25 ℃에서 MeOH 용매 4mL에 1-naphthylethylenediamine dihydrochloride 103.6mg 및 Et3N을 80㎕를 첨가하고 20분 동안 교반한 후 Phthalic anhydride 71.1mg을 첨가한 뒤에 약 115 ℃환류 장치에서 6시간 동안 합성하여 3차 아민기를 포함하는 화합물 D를 제조하였다. 화합물 D의 몰질량은 316.36 g/mol이다. 화합물 D의 NMR은 도 3a-도 3b과 같다.At room temperature (approximately 25°C), 103.6 mg of 1-naphthylethylenediamine dihydrochloride and 80 μL of Et3N were added to 4 mL of MeOH solvent, stirred for 20 minutes, 71.1 mg of phthalic anhydride was added, and then synthesized in a reflux apparatus at approximately 115°C for 6 hours to prepare compound D containing a tertiary amine group. The molar mass of compound D is 316.36 g/mol. The NMR of compound D is as shown in Figures 3a and 3b.
여기서, 도 3a와 도 3b는, 단일의 도면을 C선으로 분리하여 표현한 것으로, 도 3a는 좌측을 표현하고, 도 3b는 우측을 표현한다.Here, Figures 3a and 3b represent a single drawing divided by line C, with Figure 3a representing the left side and Figure 3b representing the right side.
[화합물 D][Compound D]
반응 전 유색성Color before reaction
실시예 1Example 1
제조예 1에서 제조된 화합물 A 5mg을 1mL의 5% sulfuric acid로 4mL의 조성물 A를 제조하고, 제조예 2에서 제조된 화합물 B를 상기 조성물 A와 1:1의 비율로 혼합하였다.5 mg of compound A prepared in Manufacturing Example 1 was mixed with 1 mL of 5% sulfuric acid to prepare 4 mL of composition A, and compound B prepared in Manufacturing Example 2 was mixed with the composition A at a ratio of 1:1.
실시예 2Example 2
화합물 B 대신 제조예 3에서 제조된 화합물 C를 포함한 것을 제외하고는 실시예 1과 동일하게 혼합하였다.The mixture was mixed in the same manner as in Example 1, except that Compound C prepared in Manufacturing Example 3 was included instead of Compound B.
실시예 3Example 3
화합물 B 대신 제조예 4에서 제조된 화합물 D를 포함한 것을 제외하고는 실시예 1과 동일하게 혼합하였다.The mixture was mixed in the same manner as in Example 1, except that Compound D prepared in Manufacturing Example 4 was included instead of Compound B.
NaNO2 반응 후 색 변화Color change after NaNO 2 reaction
상기 반응 전 유색성을 확인한 실시예 1 내지 실시예 3 혼합물에 NaNO2 0.1mg을 1mL의 H2O로 희석한 조성물을 떨어뜨린 직 후 색변화를 관찰하였다. 또한, NaNO2 첨가 후 10분 경과 후의 색변화를 관찰하였다.A composition containing 0.1 mg of NaNO 2 diluted with 1 mL of H 2 O was dropped into the mixture of Examples 1 to 3, which confirmed the colorability before the above reaction, and the color change was observed immediately thereafter. In addition, the color change was observed 10 minutes after the addition of NaNO 2 .
NaNO2로 형성된 NO+는 제조예 1에서 제조된 화합물 A의 -NH2와 반응하여 다이아조늄염을 형성하고, 이렇게 형성된 다이아조늄염이 제조예 2 내지 제조예 4에서 제조된 화합물 B 내지 화합물 D 중 어느 하나와 반응함으로써 N≡N 결합을 사이에 두고 나프탈렌기와 벤젠기를 포함하는 Azo dye를 형성함으로써 붉은색 계열의 색을 발현하다.NO + formed by NaNO 2 reacts with -NH 2 of compound A prepared in Manufacturing Example 1 to form a diazonium salt, and the diazonium salt thus formed reacts with any one of compounds B to D prepared in Manufacturing Examples 2 to 4 to form an Azo dye containing a naphthalene group and a benzene group with an N≡N bond therebetween, thereby expressing a red color.
도 4는 실시예의 유색성 및 색변화를 관찰한 결과이다.Figure 4 shows the results of observing the color and color change of the example.
실시예 1 내지 실시예 3의 혼합물은, NaNO2와 반응을 진행하기 전에도 유색성을 띤다. 또한, NaNO2가 첨가되어 반응이 진행되는 경우에는 빠르게 Azo dye를 형성하여 색변화를 일으키며, 반응이 10분가량 경과한 때에는 더욱 짙은 색을 나타내었다.이를 통해, 본 명세서에서 개시하는 화합물 또는 이를 포함하는 조성물은, 생체 성분과의 반응 전에는 유색을 띠어 색변화가 없거나 감지되지 않는 화합물 또는 이를 포함하는 조성물일 수 있음을 확인하였다.The mixtures of Examples 1 to 3 are colored even before reacting with NaNO 2. In addition, when NaNO 2 is added and the reaction proceeds, an Azo dye is quickly formed, causing a color change, and when the reaction has elapsed for about 10 minutes, an even darker color is exhibited. Through this, it was confirmed that the compound disclosed in the present specification or a composition containing the same may be a compound or a composition containing the same that is colored before reacting with a biological component and does not or cannot detect a color change.
또한, 본 명세서에서 개시하는 화합물 또는 이를 포함하는 조성물은 생체 성분과의 반응 후에는 색변화를 발현하여 생체 성분을 확인할 수 있는 화합물 또는 이를 포함하는 조성물일 수 있음을 확인하였다.In addition, it was confirmed that the compound disclosed in the present specification or a composition containing the same can be a compound or a composition containing the same that can identify a biological component by exhibiting a color change after reaction with the biological component.
전술한 본원의 설명은 예시를 위한 것이며, 본원이 속하는 기술분야의 통상의 지식을 가진 자는 본원의 기술적 사상이나 필수적인 특징을 변경하지 않고서 다른 구체적인 형태로 쉽게 변형이 가능하다는 것을 이해할 수 있을 것이다. 그러므로 이상에서 기술한 실시예들은 모든 면에서 예시적인 것이며 한정적이 아닌 것으로 이해해야만 한다. The above description of the present invention is for illustrative purposes only, and those skilled in the art will readily appreciate that the present invention can be readily modified into other specific forms without altering the technical spirit or essential characteristics of the present invention. Therefore, the embodiments described above should be understood as illustrative in all respects and not restrictive.
본원의 범위는 상기 상세한 설명보다는 후술하는 특허청구범위에 의하여 나타내어지며, 특허청구범위의 의미 및 범위 그리고 그 균등 개념으로부터 도출되는 모든 변경 또는 변형된 형태가 본원의 범위에 포함되는 것으로 해석되어야 한다.The scope of the present invention is indicated by the claims described below rather than the detailed description above, and all changes or modifications derived from the meaning and scope of the claims and their equivalent concepts should be interpreted as being included in the scope of the present invention.
Claims (8)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR10-2024-0030654 | 2024-03-04 | ||
| KR1020240030654A KR20250134338A (en) | 2024-03-04 | 2024-03-04 | Compound that changes color by reacting with components in the body |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| WO2025187876A1 true WO2025187876A1 (en) | 2025-09-12 |
| WO2025187876A8 WO2025187876A8 (en) | 2025-10-02 |
Family
ID=96990961
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/KR2024/009983 Pending WO2025187876A1 (en) | 2024-03-04 | 2024-07-12 | Compound which changes color by reacting with bodily substance |
Country Status (2)
| Country | Link |
|---|---|
| KR (1) | KR20250134338A (en) |
| WO (1) | WO2025187876A1 (en) |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8003399B2 (en) * | 2005-08-31 | 2011-08-23 | Kimberly-Clark Worldwide, Inc. | Nitrite detection technique |
| US8557894B2 (en) * | 2009-12-17 | 2013-10-15 | Kimberly-Clark Worldwide, Inc. | Water-triggered coloring or color changing indicator |
| WO2017223147A1 (en) * | 2016-06-23 | 2017-12-28 | Life Technologies Corporation | Methods and compositions for detecting or measuring caspases or apoptosis |
| KR20180048074A (en) * | 2016-11-02 | 2018-05-10 | 주식회사 씨스퀘어 | Means for detecting malondialdehyde in urine |
-
2024
- 2024-03-04 KR KR1020240030654A patent/KR20250134338A/en active Pending
- 2024-07-12 WO PCT/KR2024/009983 patent/WO2025187876A1/en active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8003399B2 (en) * | 2005-08-31 | 2011-08-23 | Kimberly-Clark Worldwide, Inc. | Nitrite detection technique |
| US8557894B2 (en) * | 2009-12-17 | 2013-10-15 | Kimberly-Clark Worldwide, Inc. | Water-triggered coloring or color changing indicator |
| WO2017223147A1 (en) * | 2016-06-23 | 2017-12-28 | Life Technologies Corporation | Methods and compositions for detecting or measuring caspases or apoptosis |
| KR20180048074A (en) * | 2016-11-02 | 2018-05-10 | 주식회사 씨스퀘어 | Means for detecting malondialdehyde in urine |
Non-Patent Citations (1)
| Title |
|---|
| BICHENKOVA, E. V. ET AL.: "Target-assembled tandem oligonucleotide systems based on exciplexes for detecting DNA mismatches and single nucleotide polymorphisms", BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, vol. 332, 2005, pages 956 - 964, XP027218732, DOI: 10.1016/j.bbrc.2005.05.048 * |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2025187876A8 (en) | 2025-10-02 |
| KR20250134338A (en) | 2025-09-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA1154781A (en) | Aminoantipyrine compounds and the use thereof | |
| WO2016117814A2 (en) | Novel crystal form of benzimidazole derivative and preparation method thereof | |
| WO2025187876A1 (en) | Compound which changes color by reacting with bodily substance | |
| WO2016043462A2 (en) | Method for preparing calcobutrol | |
| WO2019004677A1 (en) | Polyimide precursor composition, preparation method therefor, and polyimide substrate manufactured therefrom | |
| WO2011013922A9 (en) | Surface treating agent composition, method for preparing same, copper foil for a printed circuit board, and flexible copper clad laminate | |
| WO2014185740A1 (en) | Novel acid dianhydride, method for preparing same, and polyimide prepared therefrom | |
| IT8147774A1 (en) | PROCEDURE FOR PRODUCING TRIARYL-METHANE COMPOUNDS. | |
| WO2020204647A1 (en) | Processes for preparing (3r,4r)-1-benzyl-n,4-dimethylpiperidin-3-amine or a salt thereof and processes for preparing tofacitinib using the same | |
| KR20250129990A (en) | Compound that changes color by reacting with components in the body | |
| US4336383A (en) | 1-1-Binaphthyl-4,4',5,5',8,8'-hexacarboxylic acid compounds, method of preparation and use thereof for the synthesis of asymmetric derivatives of 3,4,9,10-perylenetetracarboxylic acid, and for dyeing and printing of textile materials | |
| KR20250119081A (en) | Compound that changes color by reacting with components in the body | |
| WO2023239104A1 (en) | Method for preparing dihydroxyammonium 5,5'-bistetrazole-1,1'-diolate | |
| WO2022080812A1 (en) | Method for preparing intermediate for synthesis of sphingosine-1-phosphate receptor agonist | |
| WO2021150052A1 (en) | Novel gadolinium-based compound, preparation method therefor, and mri contrast agent containing same | |
| WO2018190647A2 (en) | Self-healing functional polyvinyl-based compound and preparation method thereof | |
| WO2019182393A1 (en) | Compound having novel structure, anti-inflammatory agent comprising same, and matrix metalloprotease-9 inhibitor comprising same | |
| WO2013180403A1 (en) | Process for preparing gefitinib and an intermediate used for preparing thereof | |
| WO2023101329A1 (en) | Polyamic acid composition and polyimide film prepared with the same | |
| WO2019132444A1 (en) | Kit for diagnosing infection with methicillin-resistant staphylococcus aureus (mrsa) through detection of magnesium ion | |
| US3959285A (en) | Imides of 1,1'-dinaphthyl-4,4',5,5',8,8'-hexacarboxylic acid | |
| WO2021107514A2 (en) | Method for preparing lifitegrast | |
| WO2018012812A1 (en) | Sulfide-based polymer, film comprising same, and manufacturing method therefor | |
| WO2024111793A1 (en) | Compound for near-infrared absorption filter, composition comprising same, and near-infrared absorption film comprising cured product thereof | |
| WO2022030754A1 (en) | Hydrogel coating composition for chemical sensor and chemical sensor fabricated using same |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 24928675 Country of ref document: EP Kind code of ref document: A1 |